The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
[XMU-MP-1 co-treated with U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased expression of BAX protein]; XMU-MP-1 inhibits the reaction [fisetin results in increased expression of BAX protein]
[XMU-MP-1 co-treated with pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein]; XMU-MP-1 inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein]
[XMU-MP-1 co-treated with U 0126 co-treated with pyrazolanthrone] inhibits the reaction [fisetin results in increased cleavage of CASP3 protein]; XMU-MP-1 inhibits the reaction [fisetin results in increased cleavage of CASP3 protein]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased cleavage of CASP3 protein]
[XMU-MP-1 co-treated with pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of CCN2 protein]; XMU-MP-1 inhibits the reaction [fisetin results in decreased expression of CCN2 protein] [XMU-MP-1 co-treated with Cadmium Chloride] results in increased expression of CCN2 mRNA; Verteporfin inhibits the reaction [[XMU-MP-1 co-treated with Cadmium Chloride] results in increased expression of CCN2 mRNA]
XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of EPCAM mRNA]; XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of EPCAM protein]
XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of KLF4 mRNA]; XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of KLF4 protein]
XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased cleavage of CASP3 protein]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased phosphorylation of JUN protein]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased phosphorylation of MAPK1 protein]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased phosphorylation of MAPK3 protein]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased phosphorylation of YAP1 protein]
[Verteporfin co-treated with XMU-MP-1] promotes the reaction [Cadmium Chloride results in increased expression of MT1 mRNA]; XMU-MP-1 promotes the reaction [Cadmium Chloride results in increased expression of MT1 mRNA] XMU-MP-1 promotes the reaction [Cadmium Chloride results in increased expression of MT1A mRNA]; XMU-MP-1 promotes the reaction [zinc chloride results in increased expression of MT1A mRNA]
[Verteporfin co-treated with XMU-MP-1] promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA]; XMU-MP-1 promotes the reaction [Cadmium Chloride results in increased expression of MT2 mRNA]
XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of PROM1 mRNA]; XMU-MP-1 inhibits the reaction [Dichloroacetic Acid results in decreased expression of PROM1 protein]; XMU-MP-1 inhibits the reaction [ginsenoside Rg3 results in decreased expression of PROM1 mRNA] XMU-MP-1 results in increased expression of PROM1 mRNA
XMU-MP-1 results in decreased phosphorylation of YAP1 protein XMU-MP-1 inhibits the reaction [licochalcone A results in increased expression of YAP1 protein modified form]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased phosphorylation of YAP1 protein]